Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU leaders give nod to European technology institute

This article was originally published in Clinica

Executive Summary

European leaders gathering in Brussels on March 23 for the 2006 spring summit gave a cautious go-ahead to the concept of a European technology institute (EIT). They now plan to ask the European Commission to draft firm proposals by the end of the Austrian presidency on how the EIT should be managed and financed. The EIT is the Commission's proposed new flagship for excellence in higher education, research and innovation. Its aim is mainly to help Europe improve in translating R&D results into commercial opportunities. This is particularly critical in the medtech field, where a glance at the US in comparison shows that the EU is very active in research, but is failing to maximise the potential of its research outcomes through product development.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051240

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel